Datapack

These guidelines update the previous ONS guidelines and set out the steps for prescribing ONS and provide useful advice on monitoring progress as well as for prescribing in malnutrition associated with ...
This bulletin and briefing review the place in therapy for silicone sheets and gels for the treatment of scar reduction. The supporting datapack shows local usage of these products.     Wound ...
This bulletin reviews the use of rectal irrigation to ensure proper pathways are in place before prescribing and wastage is reduced through appropriate prescribing. It is a supporting bulletin for the ...
These resources review the place in therapy for silk and antimicrobial garments to ensure to ensure prescribing is appropriate and excessive quantities of garments are not prescribed. The evidence to support ...
Created on 02 February 2017
Due to concerns over hypnotic dependence, hypnotic prescribing has been subject to scrutiny and review for a number of years. In this bulletin, we offer advice on managing new patients with insomnia, recommend ...
This bulletin and associated resources support medicines optimisation in non neuropathic (non cancer) pain.  It looks at the place in therapy of different pain treatments and also helps identify where ...
This bulletin is the latest SPOT(Specials Prescribing Optimisation Tool) support bulletin and focuses on the use of glycopyrronium in hypersalivation (both off label and unlicenced special usage). It also ...
The infant feeds bulletin update is now available for subscribers. The bulletin discusses management and review for several conditions where baby milks may be prescribed and also the review of prescribed ...
Created on 28 September 2016
The Specials Prescribing Optimisation Tool (SPOT) is based on the national specials prescribing data. This list includes specials that appear regularly in the top ten specials prescribed list, those where ...
This bulletin reviews the place in therapy of unlicensed buccal midazolam and switching to a licences product where appropriate. Safety issues and savings are also discussed.   Buccal midazolam ...
This bulletin is an update to the oral hypoglycaemics and other antidiabetic drugs bulletin. It discusses the evidence base for the currently available antidiabetic drugs (including newer treatment agents) ...
This bulletin reviews the place in therapy the different types of surgical adhesive tapes. Advice on appropriate use and cost comparison charts are included.   Wound care - Surgical adhesive ...
Created on 17 August 2016
... There are two briefings and datapacks to support this bulletin. One is for switching from quetiapine XL to quetiapine immediate release (IR) or cost effective branded products where applicable, and the ...
This bulletin is is part of our DROP list support bulletins and reviews the place in therapy for tadalafil once daily doses. It complements our resources on erectile dysfunction for which the supporting ...
Created on 14 June 2016
The constipation bulletin reviews the treatments available for constipation (including newer therapies) and provides advice and guidance on when they should be used and for how long. Patient information, ...
Created on 31 May 2016
This resource  supports the review of prescribing of sunscreens to ensure that any prescribing is for products on the ACBS list and that it meets ACBS criteria. A patient information leaflet advising ...
Immediate release fentanyl has a NICE do not do as a first line treatment for breakthrough pain. This bulletin which is a DROP list support bulletin will focus on fentanyl immediate-release formulations ...
Negative pressure wound therapy (NPWT) is increasingly being used as a treatment option for acute, chronic and surgical wounds, and is also being used within community environments. This bulletin will ...
Soft polymer dressings aim to reduce trauma on removal of the dressing. This bulletin discusses their place in therapy and focuses on ensuring that they are prescribed only when there is a specific need ...
These resources review the place in therapy of dosulepin which is listed as a NICE 'do not do'. The drug has a very small margin of safety between the maximum therapeutic dose and potentially fatal ...